DEROVAN NETANEL (Chief Legal Officer) received a stock award from ORAMED PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/20/2023ACC: 0001209191-23-024941
Officer· Chief Legal Officer
Since Jan 2022
+81K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
81K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+81K
Price / share
—
Trade value
—
% of position
168.8%
4/17/2023
48K→129K
Total
Net shares
+81K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2023 | A · Award | +81K | — | — | 168.8% | 48K | 129K |
| Total | +81K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported